Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries LAWSUITS FILED AGAINST BZ, SLQT and ANVS - Jakubowitz Law Pursues Shareholders Claims By: Jakubowitz Law via AccessWire September 09, 2021 at 14:15 PM EDT NEW YORK, NY / ACCESSWIRE / September 9, 2021 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies who purchased shares within the class periods listed below. Shareholders interested in representing the class of wronged shareholders have until the lead plaintiff deadline to petition the court. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. For more details and to speak with our firm without cost or obligation, follow the links below.Kanzhun Limited (NASDAQ:BZ)CONTACT JAKUBOWITZ ABOUT BZ:https://claimyourloss.com/securities/kanzhun-limited-loss-submission-form/?id=19442&from=1Class Period: June 11, 2021 - July 2, 2021Lead Plaintiff Deadline: September 10, 2021The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) Kanzhun would face an imminent cybersecurity review by the Cyberspace Administration of China ("CAC"); (2) the CAC would require Kanzhun to suspend new user registration on its BOSS Zhipin app; (3) Kanzhun needed to "to conduct a comprehensive examination of cybersecurity risks"; (4) Kanzhun needed to "enhance its cybersecurity awareness and technology capabilities"; and (5) as a result, Defendants' statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.Selectquote, Inc. (NYSE:SLQT)CONTACT JAKUBOWITZ ABOUT SLQT:https://claimyourloss.com/securities/selectquote-inc-loss-submission-form/?id=19442&from=1Class Period: February 8, 2021 - May 11, 2021Lead Plaintiff Deadline: October 15, 2021The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) SelectQuote's 2019 cohort was underperforming; (2) as a result, the Company's financial results would be adversely impacted; and (3) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.Annovis Bio, Inc. (NYSE:ANVS)CONTACT JAKUBOWITZ ABOUT ANVS:https://claimyourloss.com/securities/annovis-bio-inc-loss-submission-form/?id=19442&from=1Class Period : May 21, 2021 - July 28, 2021Lead Plaintiff Deadline : October 18, 2021The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) Annovis's ANVS401 (Posiphen), an orally administrated drug which purportedly inhibited the synthesis of neurotoxic proteins that are the main cause of neurodegeneration, did not show statistically significant results across two patient populations as to factors such as orientation, judgement, and problem solving; and (2) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.Jakubowitz Law is vigorous in pursuit of justice for shareholders who have been the victim of securities fraud. Attorney advertising. Prior results do not guarantee similar outcomes.CONTACT:JAKUBOWITZ LAW1140 Avenue of the Americas9th FloorNew York, New York 10036T: (212) 867-4490F: (212) 537-5887SOURCE: Jakubowitz Law View source version on accesswire.com: https://www.accesswire.com/663424/LAWSUITS-FILED-AGAINST-BZ-SLQT-and-ANVS--Jakubowitz-Law-Pursues-Shareholders-Claims Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
LAWSUITS FILED AGAINST BZ, SLQT and ANVS - Jakubowitz Law Pursues Shareholders Claims By: Jakubowitz Law via AccessWire September 09, 2021 at 14:15 PM EDT NEW YORK, NY / ACCESSWIRE / September 9, 2021 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies who purchased shares within the class periods listed below. Shareholders interested in representing the class of wronged shareholders have until the lead plaintiff deadline to petition the court. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. For more details and to speak with our firm without cost or obligation, follow the links below.Kanzhun Limited (NASDAQ:BZ)CONTACT JAKUBOWITZ ABOUT BZ:https://claimyourloss.com/securities/kanzhun-limited-loss-submission-form/?id=19442&from=1Class Period: June 11, 2021 - July 2, 2021Lead Plaintiff Deadline: September 10, 2021The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) Kanzhun would face an imminent cybersecurity review by the Cyberspace Administration of China ("CAC"); (2) the CAC would require Kanzhun to suspend new user registration on its BOSS Zhipin app; (3) Kanzhun needed to "to conduct a comprehensive examination of cybersecurity risks"; (4) Kanzhun needed to "enhance its cybersecurity awareness and technology capabilities"; and (5) as a result, Defendants' statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.Selectquote, Inc. (NYSE:SLQT)CONTACT JAKUBOWITZ ABOUT SLQT:https://claimyourloss.com/securities/selectquote-inc-loss-submission-form/?id=19442&from=1Class Period: February 8, 2021 - May 11, 2021Lead Plaintiff Deadline: October 15, 2021The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) SelectQuote's 2019 cohort was underperforming; (2) as a result, the Company's financial results would be adversely impacted; and (3) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.Annovis Bio, Inc. (NYSE:ANVS)CONTACT JAKUBOWITZ ABOUT ANVS:https://claimyourloss.com/securities/annovis-bio-inc-loss-submission-form/?id=19442&from=1Class Period : May 21, 2021 - July 28, 2021Lead Plaintiff Deadline : October 18, 2021The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) Annovis's ANVS401 (Posiphen), an orally administrated drug which purportedly inhibited the synthesis of neurotoxic proteins that are the main cause of neurodegeneration, did not show statistically significant results across two patient populations as to factors such as orientation, judgement, and problem solving; and (2) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.Jakubowitz Law is vigorous in pursuit of justice for shareholders who have been the victim of securities fraud. Attorney advertising. Prior results do not guarantee similar outcomes.CONTACT:JAKUBOWITZ LAW1140 Avenue of the Americas9th FloorNew York, New York 10036T: (212) 867-4490F: (212) 537-5887SOURCE: Jakubowitz Law View source version on accesswire.com: https://www.accesswire.com/663424/LAWSUITS-FILED-AGAINST-BZ-SLQT-and-ANVS--Jakubowitz-Law-Pursues-Shareholders-Claims